{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:20:49Z","timestamp":1768699249365,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["2015.0643"],"award-info":[{"award-number":["2015.0643"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.critrevonc.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T09:38:53Z","timestamp":1555839533000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-5097","authenticated-orcid":false,"given":"Guido","family":"Frosina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Marubbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Daga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.critrevonc.2019.04.015_bib0005","volume":"17","author":"Abida","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.critrevonc.2016.08.008","article-title":"ATM mutation and radiosensitivity: an opportunity in the therapy of mantle cell lymphoma","volume":"107","author":"Ahmed","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1167\/iovs.13-13461","article-title":"Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis","volume":"55","author":"Alekseev","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6853","article-title":"Origin of the U87MG glioma cell line: good news and bad news","volume":"8","author":"Allen","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28157-8","article-title":"Quiescence status of glioblastoma stem-like cells involves remodelling of ca(2+) signalling and mitochondrial shape","volume":"8","author":"Aulestia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0035","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1535-7163.MCT-12-0707","article-title":"Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer","volume":"12","author":"Batey","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0040","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation","volume":"19","author":"Biddlestone-Thorpe","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","article-title":"Current and future strategies for treatment of glioma","volume":"40","author":"Bush","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1634\/theoncologist.2016-0145","article-title":"A phase ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma","volume":"21","author":"Carlo","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0055","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1073\/pnas.1716892115","article-title":"ATM and ATR play complementary roles in the behavior of excitatory and inhibitory vesicle populations","volume":"115","author":"Cheng","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/dvdy.24522","article-title":"Neurodegeneration in ataxia-telangiectasia: multiple roles of ATM kinase in cellular homeostasis","volume":"247","author":"Choy","year":"2018","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0740-5","article-title":"Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gOv","volume":"12","author":"Cihoric","year":"2017","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0075","series-title":"Safety Evaluation of Drugs & Chemicals","first-page":"158","article-title":"Microbial and mammalian cell systems for detecting mutagens","author":"Clark","year":"1986"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0080","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.2006.094268","article-title":"Survival probability in ataxia telangiectasia","volume":"91","author":"Crawford","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0085","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jmedchem.6b00519","article-title":"Discovery of novel 3-quinoline carboxamides as potent, selective, and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase","volume":"59","author":"Degorce","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0090","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b00936","article-title":"Correction to discovery of novel 3-quinoline carboxamides as potent, selective, and orally bioavailable inhibitors of ataxia telangiectasia mutated (ATM) kinase","author":"Degorce","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0095","doi-asserted-by":"crossref","first-page":"e9747","DOI":"10.1097\/MD.0000000000009747","article-title":"The association of single nucleotide polymorphism rs189037C&T in ATM gene with coronary artery disease in Chinese Han populations: a case control study","volume":"97","author":"Ding","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.redox.2017.11.006","article-title":"Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia","volume":"14","author":"Duecker","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuchi.2014.02.008","article-title":"Early presentation of primary glioblastoma","author":"Faguer","year":"2014","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1541-7786.MCR-09-0030","article-title":"DNA repair and resistance of gliomas to chemotherapy and radiotherapy","volume":"7","author":"Frosina","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0120","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.2174\/0929867311320260011","article-title":"Development of therapeutics for high grade gliomas using orthotopic rodent models","volume":"20","author":"Frosina","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-1020-3","article-title":"ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration","volume":"13","author":"Frosina","year":"2018","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32578-w","article-title":"Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1","volume":"8","author":"Frosina","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0140","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM","volume":"64","author":"Hickson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/en.2017-00652","article-title":"ATM is required for the prolactin-induced HSP90-mediated increase in cellular viability and clonogenic growth after DNA damage","volume":"159","author":"Karayazi Atici","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0150","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1158\/1535-7163.MCT-17-0975","article-title":"Orally bioavailable and blood-brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice","volume":"17","author":"Karlin","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0155","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1212\/NXG.0000000000000228","article-title":"Ataxia-telangiectasia: a new remitting form with a peculiar transcriptome signature","volume":"4","author":"Leuzzi","year":"2018","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0160","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3892\/or.2016.4754","article-title":"Silencing of ataxia-telangiectasia mutated by siRNA enhances the in vitro and in vivo radiosensitivity of glioma","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0165","first-page":"548","article-title":"Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM\/p21 pathway","volume":"41","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0170","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-018-2838-0","article-title":"ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation","author":"Lim","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/path.5018","article-title":"EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma","volume":"244","author":"Lung","year":"2018","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.015_bib0180","article-title":"Human papillomaviruses preferentially recruit DNA repair factors to viral genomes for rapid repair and amplification","volume":"9","author":"Mehta","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.23239","article-title":"Impact of X-irradiation on microglia","volume":"66","author":"Menzel","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0190","doi-asserted-by":"crossref","first-page":"35376","DOI":"10.18632\/oncotarget.15686","article-title":"Epithelial-mesenchymal transition in prostate cancer: an overview","volume":"8","author":"Montanari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0195","doi-asserted-by":"crossref","DOI":"10.1667\/RR14781.1","article-title":"Ataxia-telangiectasia mutated (ATM) kinase regulates eNOS expression and modulates radiosensitivity in endothelial cells exposed to ionizing radiation","author":"Nagane","year":"2018","journal-title":"Radiat. Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2712-4","article-title":"Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models","volume":"16","author":"Netland","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0205","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1719988115","article-title":"DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions","volume":"115","author":"Panchakshari","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semcancer.2018.01.015","article-title":"Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment","volume":"52","author":"Passiglia","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0215","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1634\/theoncologist.2016-0243","article-title":"BEZ235: when promising science meets clinical reality","volume":"21","author":"Pongas","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.radonc.2017.09.043","article-title":"ATR\/CHK1 inhibitors and cancer therapy","volume":"126","author":"Qiu","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0225","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1750-3639.2012.00566.x","article-title":"Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein","volume":"22","author":"Raso","year":"2012","journal-title":"Brain Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.015_bib0230","article-title":"The epithelial-to-mesenchymal transition in cancer","volume":"10","author":"Roche","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0235","article-title":"Breaking the DNA damage response via serine\/threonine kinase inhibitors to improve cancer treatment","author":"Rozpedek","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajpath.2017.10.005","article-title":"Epigenetic mechanisms of ATM activation after helicobacter pylori infection","volume":"188","author":"Santos","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.critrevonc.2018.03.024","article-title":"Re-irradiation as salvage treatment in recurrent glioblastoma: a comprehensive literature review to provide practical answers to frequently asked questions","volume":"126","author":"Scoccianti","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2018.00073","article-title":"Ataxia-telangiectasia mutated kinase in the control of oxidative stress, mitochondria, and autophagy in cancer: a maestro with a large orchestra","volume":"8","author":"Stagni","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0255","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00042.2018","article-title":"Ataxia-telangiectasia mutated kinase deficiency impairs autophagic response early during myocardial infarction","author":"Thrasher","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1389450115666141110154621","article-title":"Targeting the ataxia telangiectasia mutated protein in cancer therapy","volume":"17","author":"Vecchio","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0265","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.28680","article-title":"Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019","volume":"135","author":"Vecchio","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0270","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.29121","article-title":"Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019","volume":"136","author":"Vecchio","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0275","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2017.11.021","article-title":"Rapamycin enhances lytic replication of epstein-barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters","volume":"244","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2018.03.001","article-title":"Pentose phosphate pathway activation via HSP27 phosphorylation by ATM kinase: a putative endogenous antioxidant defense mechanism during cerebral ischemia-reperfusion","volume":"1687","author":"Yamamoto","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0285","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-018-1142-y","article-title":"Inflammation, a significant player of ataxia-telangiectasia pathogenesis?","author":"Zaki-Dizaji","year":"2018","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0290","first-page":"7045","article-title":"ATMJAKPDL1 signaling pathway inhibition decreases EMT and metastasis of androgenindependent prostate cancer","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0295","article-title":"ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2019.04.015_bib0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-018-0015-4","article-title":"Insufficiency of DNA repair enzyme ATM promotes naive CD4 T-cell loss in chronic hepatitis C virus infection","volume":"4","author":"Zhao","year":"2018","journal-title":"Cell Discov."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:31:55Z","timestamp":1760902315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842819300794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":60,"alternative-id":["S1040842819300794"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.015","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}